Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online:162
  • Home
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2020  |  Volume : 5  |  Issue : 2  |  Page : 182-186

Assessment of noncryopreserved stem cell viability (CD34+) at 4°C


1 Department of Transfusion Medicine, Rajiv Gandhi Cancer Institute and Research Center, Delhi, India
2 Department of Laboratory Medicine, Rajiv Gandhi Cancer Institute and Research Center, Delhi, India
3 Department of Laboratory Medicine, Sir Ganga Ram Hospital, Delhi, India
4 Department of TB, Jagjivan Ram Memorial Hospital, New Delhi, India

Correspondence Address:
Amardeep Pathak
Department of Transfusion Medicine, Rajiv Gandhi Cancer Institute and Research Center, Delhi
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/GJTM.GJTM_87_20

Rights and Permissions

Background and Objectives: Stem cell transplantation is one of the mainstay treatment modality for many benign and malignant disorders. Long- and short-term storage of stem cell is a crucial step. Long-term storage is using temperature-controlled preservation with liquid or vapor nitrogen at − 196°C. Short-term storage at 4°C ± 2°C is done for those products, which are intended to be infused within a few days after the collection. The current study was done to assess the viability of noncryopreserved stem cells at 4°C up to 9 days. Methods: CD34 enumeration was done on day 0, 3, 5, 7, and 9 of the collection in 12 consecutive cases of stem cell harvest. Enumeration was done using ISHAGE protocol, and viability was measured using 7-AAD dye with “BD Stem kit” on single platform bead-based assay. Viability of the samples was compared at various time points and also with respect to their source (autologous versus allogeneic). The results were expressed as mean (range), and significance was calculated using Mann–Whitney test. Results: A total of seven allogeneic and five autologous products were included. All the autologous products are stable till 5th day when stored at 4°C ± 2°C with none of the product showing >15% viability loss. However, the allogeneic products are stable up to day 3 only. On day 5, most 29% of the allogeneic products were showing >15% loss of viability. Conclusions: Storage up to day 7 or 9 was associated with unacceptable loss of viability for both autologous and allogeneic products.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed60    
    Printed2    
    Emailed0    
    PDF Downloaded5    
    Comments [Add]    

Recommend this journal